Source comparison
Follistatin-344 vs Sermorelin: Research Comparison
Follistatin-344 and Sermorelin represent two distinct research peptides with non-overlapping mechanisms. One inhibits myostatin to remove genetic brakes on muscle growth, the other amplifies the body's own growth hormone secretion through hypothalamic-pituitar
This comparison does not assign a generated winner or score.
- Follistatin-344 and Sermorelin represent two distinct research peptides with non-overlapping mechanisms. One inhibits myostatin to remove genetic brakes on muscle growth, the other amplifies the body's own growth hormone secretion through hypothalamic-pituitary axis modulation. A 2019 study published in Frontiers in Endocrinology found that follistatin administration in animal models increased lean muscle mass by 35% over 12 weeks without exogenous growth hormone, while Sermorelin trials demonstrated mean GH pulse amplitude increases of 2.8-fold within 28 days. The distinction matters: researchers investigating muscle hypertrophy pathways independent of GH use follistatin; those studying age-related GH decline restoration use Sermorelin.
- Our team at Real Peptides has synthesized both compounds for research institutions across multiple continents. The confusion about which peptide 'works better' stems from comparing two tools designed for entirely different biological endpoints.
- What's the core difference between Follistatin-344 and Sermorelin in research applications?
- Follistatin-344 functions as a myostatin inhibitor. Binding to myostatin and activin proteins to prevent them from limiting muscle fiber growth. Sermorelin (GRF 1-29) acts as a growth hormone-releasing hormone (GHRH) analog, stimulating the anterior pituitary to release endogenous growth hormone in physiological pulses. Follistatin's half-life is approximately 3 hours; Sermorelin's is 8–12 minutes, requiring different dosing protocols. Research choosing between them depends on whether the study investigates direct muscle regulation (follistatin) or systemic GH-mediated effects (Sermorelin).